Delivery Order SPE2DB24D2205-SPE2DB25FEGKM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 3, 2025, for the supply of Buprenorphine 0.3 mg/ml vials with a ceiling value of $1,041.75. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order represents a child contract under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 0.3 mg/mL buprenorphine vials. The contract has a ceiling value of $1,389.00 and a period of performance ending on June 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency awarded a $33,640 delivery order to Amerisourcebergen Drug Corporation for the supply of 30 buprenorphine 2 mg tablets. The firm fixed price order is to be performed in Conshohocken, Pennsylvania from July 13-14, 2023. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the opioid addiction treatment medication to support the Agency's health services for service members and their families. No set aside designation or...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to provide $2,778 worth of Buprenorphine 0.3 mg/ml vials. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by December 12, 2023. No set-aside designation was applied to this award to...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,669 to Amerisourcebergen Drug Corporation for the supply of 30 units of 8-2mg films of buprenorphine-naloxone. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period concluding on July 28, 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor on this...
- This federal contract award is for the delivery of BUPRENORPHINE 0.3 MG/ML VIALML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $1,389.00 and a completion date of February 29, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug...
- The Defense Logistics Agency issued a delivery order valued at $2,180.68 to AmerisourceBergen Drug Corp for the supply of Belbuca 900 mcg film (60-count package), a buprenorphine transdermal product used for pain management. This competitively awarded, firm fixed price delivery order was placed on August 1, 2025, with an ultimate completion date of August 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a $508,650 delivery order by the Defense Logistics Agency to provide Buprenorphine 15 mcg/hr patches. The firm fixed price contract will be performed in Conshohocken, Pennsylvania over a one day period beginning on August 8, 2023. No set aside designation or additional context was provided regarding the Defense Logistics Agency's programs or vehicle contracts. The single delivery order is to a...
- The Defense Logistics Agency Troop Support Medical awarded a $855.89 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561422116 Buprenorphine 20 mcg/hr patches. As the parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation will perform under the contract from its Conshohocken, Pennsylvania location from July 6-7, 2023. The delivery order was issued under an existing DLA medical product supply vehicle and provides needed...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,026.43 to AmerisourceBergen Drug Corp for 60 units of Belbuca 750 mcg film, a buprenorphine-based pain management pharmaceutical. Issued on July 31, 2025, with an ultimate completion date of August 1, 2025, this firm fixed-price delivery order was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGKMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,389.00 to AmerisourceBergen Drug Corp for the supply of Buprenorphine 0.3 mg/ml vials. The contract was competitively awarded without set-aside designation and is structured as a firm fixed-price delivery order with an ultimate completion date of August 19, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical supply supports federal medical procurement needs for military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, delivering a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This specific delivery order for buprenorphine—a controlled substance commonly used in pain management and opioid use disorder treatment—reflects the vendor's ongoing role in fulfilling medical supply requirements for the Department of Defense and related federal healthcare systems through its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/18/25 |